144 related articles for article (PubMed ID: 27178117)
21. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
22. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.
Krobot KJ; Yin DD; Alemao E; Steinhagen-Thiessen E
Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):37-45. PubMed ID: 15703504
[TBL] [Abstract][Full Text] [Related]
23. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
24. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
[TBL] [Abstract][Full Text] [Related]
25. LDL cholesterol: should guidelines include targets?
Banerjee S; Kahali D; Banerjee A; Brilakis ES
Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):285-90. PubMed ID: 24502625
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study.
Lee KK; Lee VW; Chan WK; Lee BS; Chong AC; Wong JC; Yin D; Alemao E; Tomlinson B
Value Health; 2008 Mar; 11 Suppl 1():S91-8. PubMed ID: 18387073
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
[TBL] [Abstract][Full Text] [Related]
28. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
[TBL] [Abstract][Full Text] [Related]
29. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
Rosenson R; Lloyd-Jones D;
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
[TBL] [Abstract][Full Text] [Related]
30. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
[TBL] [Abstract][Full Text] [Related]
31. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management.
Leitersdorf E
Int J Clin Pract; 2002 Mar; 56(2):116-9. PubMed ID: 11926698
[TBL] [Abstract][Full Text] [Related]
32. An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors.
Makkar KM; Sanoski CA; Goldberg LR; Spinler SA
Ann Pharmacother; 2013 Nov; 47(11):1457-62. PubMed ID: 24285762
[TBL] [Abstract][Full Text] [Related]
33. Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study.
Tomasik T; Jozwiak J; Windak A; Rygiel K; Mastej M; Smithson WH; Mathers N; Tomaszewski M; Kaess BM; Tykarski A; Konduracka E; Grzeszczak W; Lukas W
Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):287-96. PubMed ID: 21450675
[TBL] [Abstract][Full Text] [Related]
34. The impact of lipid lowering in coronary artery disease.
Goldberg AC
Curr Opin Cardiol; 1997 Sep; 12(5):488-93. PubMed ID: 9352177
[TBL] [Abstract][Full Text] [Related]
35. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
36. Lipid management in a private cardiology practice (the Midwest Heart experience).
Brown AS; Cofer LA
Am J Cardiol; 2000 Feb; 85(3A):18A-22A. PubMed ID: 10695703
[TBL] [Abstract][Full Text] [Related]
37. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients.
Bruckert E; Pouchain D; Auboiron S; Mulet C
Arch Cardiovasc Dis; 2012 Nov; 105(11):557-65. PubMed ID: 23177484
[TBL] [Abstract][Full Text] [Related]
38. Clinical inquiries. Which patients benefit from lowering LDL to <100 mg/dL?
Evensen A; Elliott M; Hooper-Lane C
J Fam Pract; 2010 Dec; 59(12):706-8. PubMed ID: 21135927
[TBL] [Abstract][Full Text] [Related]
39. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
40. Management of dyslipidemia in primary care.
Alzahrani T; Marrat S; Haider A
Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
